Goserelin acetate 50 mg | 100.00%
TargetMol
Goserelin acetate is a synthetic long-acting agonist of gonadotropin-releasing hormone, used in treatments of cancer.
More Information Supplier Page
Goserelin acetate is a synthetic long-acting agonist of gonadotropin-releasing hormone, used in treatments of cancer.
More Information Supplier Page
Goserelin acetate is a synthetic long-acting agonist of gonadotropin-releasing hormone, used in treatments of cancer.
More Information Supplier Page
S 38093 is a brain-penetrant antagonist of the H3 receptor (Ki: 8.8/1.44/1.2 μM, for rat/mouse/human).
More Information Supplier Page
S 38093 is a brain-penetrant antagonist of the H3 receptor (Ki: 8.8/1.44/1.2 μM, for rat/mouse/human).
More Information Supplier Page
LY2334737 is an orally available prodrug of gemcitabine with antineoplastic activity.
More Information Supplier Page
LY2334737 is an orally available prodrug of gemcitabine with antineoplastic activity.
More Information Supplier Page
LY2334737 is an orally available prodrug of gemcitabine with antineoplastic activity.
More Information Supplier Page
LY2334737 is an orally available prodrug of gemcitabine with antineoplastic activity.
More Information Supplier Page
Selamectin is a macrocyclic lactone derivative of ivermectin, an anthelmintic that potentiates glutamate- and GABA-gated chloride channel opening in nematodes. In an H. contortus larval development assay, selamectin (0.1 μg/ml) shows the effect of growth inhibition.
More Information Supplier Page
Selamectin is a macrocyclic lactone derivative of ivermectin, an anthelmintic that potentiates glutamate- and GABA-gated chloride channel opening in nematodes. In an H. contortus larval development assay, selamectin (0.1 μg/ml) shows the effect of growth inhibition.
More Information Supplier Page